Drug intelligence / Profile preview

alanyl glutamine

Development stage
Phase 4
Modality
Peptides, Small Molecules
Administration
Intravenous, Oral
01

Overview

Alanyl glutamine is a dipeptide composed of the amino acids alanine and glutamine. It is used primarily as a nutritional supplement, especially in clinical settings for patients with nutritional deficiencies, short-term fluid replacement after trauma, critical illness, surgery, and inflammatory bowel disease. Alanyl glutamine provides a stable form of glutamine that supports protein synthesis, preserves muscle mass by inhibiting muscle breakdown and increasing muscle protein synthesis, improves electrolyte and water absorption in the intestines, enhances gut barrier function, and supports immune function. Its mechanism involves serving as a source of both alanine and glutamine to support metabolic needs during stress or illness[1][4][5][6][8].

Brand names
DipeptivenIB-GlutaOrvoglutSlagutL-GludelGlutachemGlutasterilAlphamin IVCelnylGlutaject
Other names
L-alanyl-L-glutamineAla-Gln
02

Targets

HSF1 (Heat shock factor protein 1)

Beyond the preview

Go deeper on alanyl glutamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alanyl glutamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call